(Q95720918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

title

Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

mucocutaneous leishmaniasis

29 May 2020

main subject

1 reference

V S Amato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

A R Padilha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

A C Nicodemo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

M I Duarte

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

M Valentini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

D E Uip

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

M Boulos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

V A Neto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Infectious Diseases

29 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

page(s)

153-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

Tegumentary and visceral leishmaniases in Brazil: emerging anthropozoonosis and possibilities for their control

29 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Leishmaniases of the New World: current concepts and implications for future research

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

[The use of a silicone T tube for the treatment of a case of American mucocutaneous leishmaniasis with tracheomalacia]

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

[Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B]

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

[Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis]

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Activity of imidazoles against Leishmania tropica in human macrophage cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Efficacy and Toxicity of Pentostam against Panamanian Mucosal Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Itraconazole pharmacokinetics in the female genital tract: plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Cutaneous leishmaniasis in Kuwait. Clinical experience with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

An evaluation of clinical, serologic, anatomopathologic and immunohistochemical findings for fifteen patients with mucosal leishmaniasis before and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Cutaneous leishmaniasis of the New World: diagnostic immunopathology and antigen pathways in skin and mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Imported mucocutaneous leishmaniasis in New York City. Report of a patient treated with amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Recurrent cutaneous leishmaniasis: a role for persistent parasites?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

[An evolutionary study of mucosal leishmaniasis (a 7- to 17-year follow-up) due to Leishmania (Viannia) braziliensis in Tres Braços, Bahia]

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Spontaneous clinical resolution without specific treatment in mucosal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

East African kalazar with special reference to the pathology, prophylaxis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990077-8

7 January 2021

10.1016/S1201-9712(00)90077-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179919%20AND%20SRC:MED&resulttype=core&format=json

29 May 2020

1 reference